(-0.41%) 5 460.48 points
(-0.12%) 39 119 points
(-0.71%) 17 733 points
(-0.34%) $81.46
(-3.13%) $2.60
(0.01%) $2 336.90
(0.61%) $29.44
(0.28%) $1 009.00
(-0.06%) $0.933
(0.45%) $10.68
(-0.05%) $0.791
(0.86%) $85.73
Live Chart Being Loaded With Signals
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems...
Stats | |
---|---|
Dagens volum | 54 158 |
Gjennomsnittsvolum | 20 083 |
Markedsverdi | 235.73M |
EPS | $1.090 ( Q1 | 2024-05-10 ) |
Neste inntjeningsdato | ( $0 ) 2024-07-23 |
Last Dividend | $0.300 ( 2024-06-14 ) |
Next Dividend | $0 ( N/A ) |
P/E |
14.85 (Sector) 42.63 (Industry) 0 |
ATR14 | $0.179 (0.27%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-17 | Richins Paul O | Sell | 225 | Common Stock |
2023-10-27 | Koopman Brian | Buy | 500 | Employee Stock Option - Right to Buy |
2023-06-15 | Koopman Brian | Sell | 60 | Common Stock |
2023-05-18 | Richins Paul O | Sell | 700 | Common Stock |
2023-03-17 | Richins Paul O | Sell | 150 | Common Stock |
INSIDER POWER |
---|
-28.43 |
Last 100 transactions |
Buy: 7 349 | Sell: 108 167 |
Utah Medical Products Inc Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
GOVX | 0.96 |
BIOL | 0.958 |
REVB | 0.957 |
MRBK | 0.955 |
KRNY | 0.954 |
EXTR | 0.952 |
CBNK | 0.949 |
MNSB | 0.947 |
INDB | 0.944 |
PETS | 0.944 |
10 Mest negative korrelasjoner | |
---|---|
MSVB | -0.956 |
MOR | -0.942 |
BRAC | -0.934 |
VERA | -0.933 |
FLXS | -0.929 |
CRBP | -0.926 |
APXI | -0.92 |
META | -0.918 |
EZPW | -0.917 |
LPLA | -0.917 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Utah Medical Products Inc Korrelasjon - Valuta/Råvare
Utah Medical Products Inc Økonomi
Annual | 2023 |
Omsetning: | $50.22M |
Bruttogevinst: | $24.35M (48.47 %) |
EPS: | $4.58 |
FY | 2023 |
Omsetning: | $50.22M |
Bruttogevinst: | $24.35M (48.47 %) |
EPS: | $4.58 |
FY | 2022 |
Omsetning: | $52.28M |
Bruttogevinst: | $32.20M (61.58 %) |
EPS: | $4.53 |
FY | 2021 |
Omsetning: | $49.05M |
Bruttogevinst: | $30.92M (63.03 %) |
EPS: | $4.15 |
Financial Reports:
No articles found.
Utah Medical Products Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.290 (N/A) |
$0.295 (N/A) |
$0.295 (N/A) |
$0.295 (N/A) |
$0.295 (N/A) |
$0.300 (N/A) |
$0.300 (N/A) |
$0.300 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.150 | 2004-06-14 |
Last Dividend | $0.300 | 2024-06-14 |
Next Dividend | $0 | N/A |
Payout Date | 2024-07-05 | |
Next Payout Date | N/A | |
# dividends | 81 | -- |
Total Paid Out | $22.40 | -- |
Avg. Dividend % Per Year | 1.33% | -- |
Score | 5.71 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 7.06 | |
Div. Directional Score | 9.56 | -- |
Year | Amount | Yield |
---|---|---|
2004 | $0.450 | 1.75% |
2005 | $0.630 | 2.84% |
2006 | $0.780 | 2.55% |
2007 | $0.885 | 2.68% |
2008 | $0.905 | 3.06% |
2009 | $0.925 | 3.86% |
2010 | $1.665 | 5.63% |
2011 | $0.945 | 3.50% |
2012 | $0.965 | 3.53% |
2013 | $0.985 | 2.57% |
2014 | $1.005 | 1.94% |
2015 | $1.025 | 1.77% |
2016 | $1.045 | 1.78% |
2017 | $1.065 | 1.49% |
2018 | $1.085 | 1.37% |
2019 | $1.105 | 1.30% |
2020 | $1.125 | 1.05% |
2021 | $2.86 | 3.41% |
2022 | $1.165 | 1.20% |
2023 | $1.185 | 1.21% |
2024 | $0.600 | 0.72% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
14 Jun 2024 | $0.300 | 07 May 2024 | 14 Jun 2024 | 05 Jul 2024 |
14 Mar 2024 | $0.300 | 06 Feb 2024 | 15 Mar 2024 | 03 Apr 2024 |
14 Dec 2023 | $0.300 | 31 Oct 2023 | 15 Dec 2023 | 03 Jan 2024 |
14 Sep 2023 | $0.295 | 01 Aug 2023 | 15 Sep 2023 | 03 Oct 2023 |
15 Jun 2023 | $0.295 | 09 May 2023 | 16 Jun 2023 | 06 Jul 2023 |
16 Mar 2023 | $0.295 | 07 Feb 2023 | 17 Mar 2023 | 04 Apr 2023 |
15 Dec 2022 | $0.295 | 01 Nov 2022 | 16 Dec 2022 | 04 Jan 2023 |
15 Sep 2022 | $0.290 | 02 Aug 2022 | 16 Sep 2022 | 05 Oct 2022 |
16 Jun 2022 | $0.290 | 10 May 2022 | 17 Jun 2022 | 06 Jul 2022 |
17 Mar 2022 | $0.290 | 08 Feb 2022 | 18 Mar 2022 | 05 Apr 2022 |
14 Dec 2021 | $2.00 | 02 Nov 2021 | 15 Dec 2021 | 29 Dec 2021 |
15 Sep 2021 | $0.285 | 03 Aug 2021 | 16 Sep 2021 | 05 Oct 2021 |
14 Jun 2021 | $0.285 | 11 May 2021 | 15 Jun 2021 | 06 Jul 2021 |
16 Mar 2021 | $0.285 | 09 Feb 2021 | 17 Mar 2021 | 02 Apr 2021 |
14 Dec 2020 | $0.285 | 03 Nov 2020 | 15 Dec 2020 | 05 Jan 2021 |
14 Sep 2020 | $0.280 | 11 Aug 2020 | 15 Sep 2020 | 05 Oct 2020 |
16 Jun 2020 | $0.280 | 07 May 2020 | 17 Jun 2020 | 03 Jul 2020 |
12 Mar 2020 | $0.280 | 13 Feb 2020 | 13 Mar 2020 | 02 Apr 2020 |
12 Dec 2019 | $0.280 | 05 Nov 2019 | 13 Dec 2019 | 03 Jan 2020 |
12 Sep 2019 | $0.275 | 08 Aug 2019 | 13 Sep 2019 | 03 Oct 2019 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Diamond | 2024-09-16 | Monthly | 14 | 15.03% | 9.60 |
DMLP | Dividend Diamond | 2024-04-26 | Quarterly | 22 | 10.71% | 9.35 |
OXSQ | Dividend Diamond | 2024-09-16 | Monthly | 21 | 12.73% | 9.02 |
ARLP | Dividend Royal | 2024-05-07 | Quarterly | 26 | 9.67% | 8.87 |
PNNT | Dividend Royal | 2024-06-14 | Monthly | 18 | 9.49% | 8.82 |
MFIC | Dividend Royal | 2024-06-11 | Quarterly | 21 | 10.89% | 8.79 |
SPOK | Dividend Royal | 2024-05-23 | Quarterly | 20 | 8.73% | 8.72 |
PSEC | Dividend Royal | 2024-06-25 | Monthly | 21 | 9.03% | 8.65 |
SBLK | Dividend Royal | 2024-06-06 | Quarterly | 17 | 13.10% | 8.63 |
GBDC | Dividend Royal | 2024-11-29 | Bi-Monthly | 15 | 8.53% | 8.62 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.334 | 1.500 | 3.32 | 4.98 | [0 - 0.5] |
returnOnAssetsTTM | 0.121 | 1.200 | 5.97 | 7.16 | [0 - 0.3] |
returnOnEquityTTM | 0.131 | 1.500 | 9.66 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.263 | -1.000 | 7.37 | -7.37 | [0 - 1] |
currentRatioTTM | 19.57 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 52.07 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 17.14 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.00210 | -1.500 | 9.96 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 9.20 | 1.000 | 7.71 | 7.71 | [3 - 30] |
operatingCashFlowPerShareTTM | 5.70 | 2.00 | 8.10 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 5.53 | 2.00 | 7.23 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.00223 | -1.500 | 9.99 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.573 | 1.000 | 3.79 | 3.79 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.331 | 1.000 | 5.39 | 5.39 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 72.43 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.362 | 0.800 | -0.919 | -0.735 | [0.5 - 2] |
Total Score | 12.07 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 14.77 | 1.000 | 8.61 | 0 | [1 - 100] |
returnOnEquityTTM | 0.131 | 2.50 | 9.78 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 5.53 | 2.00 | 8.16 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.789 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 5.70 | 2.00 | 8.10 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.263 | 1.500 | 7.37 | -7.37 | [0 - 1] |
pegRatioTTM | 6.66 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.421 | 1.000 | 1.978 | 0 | [0.1 - 0.5] |
Total Score | 7.06 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Utah Medical Products Inc
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices through direct customer service and sales force, independent consultants, and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.